Related Experiment Video
Updated: Aug 7, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood
Keisuke Katsushima1,2, Rudramani Pokhrel1,2, Iqbal Mahmud3,4
1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, 1650 Orleans St., Baltimore, MD, 21231, USA.
Abstract:
Medulloblastoma (MB) develops through various genetic, epigenetic, and non-coding (nc) RNA-related mechanisms, but the roles played by ncRNAs, particularly circular RNAs (circRNAs), remain poorly defined. CircRNAs are increasingly recognized as stable non-coding RNA therapeutic targets in many cancers, but little is known about their function in MBs. To determine medulloblastoma subgroup-specific circRNAs, publicly available RNA sequencing (RNA-seq) data from 175 MB patients were interrogated to identify circRNAs that differentiate between MB subgroups. circ_63706 was identified as sonic hedgehog (SHH) group-specific, with its expression confirmed by RNA-FISH analysis in clinical tissue samples. The oncogenic function of circ_63706 was characterized in vitro and in vivo. Further, circ_63706-depleted cells were subjected to RNA-seq and lipid profiling to identify its molecular function. Finally, we mapped the circ_63706 secondary structure using an advanced random forest classification model and modeled a 3D structure to identify its interacting miRNA partner molecules. Circ_63706 regulates independently of the host coding gene pericentrin (PCNT), and its expression is specific to the SHH subgroup. circ_63706-deleted cells implanted into mice produced smaller tumors, and mice lived longer than parental cell implants. At the molecular level, circ_63706-deleted cells elevated total ceramide and oxidized lipids and reduced total triglyceride. Our study implicates a novel oncogenic circular RNA in the SHH medulloblastoma subgroup and establishes its molecular function and potential as a future therapeutic target.
Insights
A novel circular RNA, circ_63706, drives medulloblastoma growth in the SHH subgroup. Depleting circ_63706 reduced tumor size and improved survival, highlighting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Medulloblastoma (MB) is a complex brain tumor with poorly understood roles for non-coding RNAs (ncRNAs).
- Circular RNAs (circRNAs), a class of ncRNAs, are emerging as potential therapeutic targets in cancer, but their function in MB is largely unknown.
Purpose of the Study:
- To identify medulloblastoma subgroup-specific circRNAs.
- To characterize the function and molecular mechanisms of a novel circRNA, circ_63706, in the sonic hedgehog (SHH) MB subgroup.
Main Methods:
- RNA sequencing (RNA-seq) analysis of 175 MB patient samples to identify subgroup-specific circRNAs.
- RNA fluorescence in situ hybridization (RNA-FISH) for expression validation.
- In vitro and in vivo functional assays (cell depletion, tumor implantation in mice).
- RNA-seq and lipid profiling of circRNA-depleted cells.
- Bioinformatic analysis including random forest classification for secondary structure mapping and 3D modeling.
Main Results:
- Identified circ_63706 as specific to the SHH MB subgroup, independent of its host gene PCNT.
- Depletion of circ_63706 significantly reduced tumor growth in vivo and prolonged mouse survival.
- Molecular analysis revealed circ_63706 depletion altered lipid metabolism, increasing ceramides and oxidized lipids while decreasing triglycerides.
- Mapped circ_63706 secondary structure and modeled its 3D structure to predict miRNA interactions.
Conclusions:
- Circ_63706 is a novel oncogenic circRNA in the SHH medulloblastoma subgroup.
- Circ_63706 plays a critical role in MB tumorigenesis and influences lipid metabolism.
- Circ_63706 represents a promising therapeutic target for SHH medulloblastoma.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Hedgehog Signaling Pathway
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers

